Vi Partners is a Swiss venture capital firm based in Altendorf, investing in technology and healthcare startups across Switzerland and Europe. Founded in 2001, it is the longest-established VC firm in Switzerland and targets early-stage companies with strong scientific and technological foundations.
49% of their portfolio is in Healthcare. Average disclosed round size is $36.3M (across 25 rounds with reported amounts).
Portfolio
40
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
MP
Magdalena Plotcyk
Principal
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
59 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Buynomics | Series B | — | Mar 2025 |
 Unique | Series A | $30M | Jan 2025 |
| UUnique | Series A | $30M | Jan 2025 |
 Somagenetix | Series A | — | Oct 2024 |
 iOnctura | Series B | — | Jun 2024 |
 Altoida | Series A | $14M | Jan 2024 |
 Flowit | Seed | — | Jan 2024 |
 SibYlla | Series A | — | Oct 2022 |
 Sibylla Biotech | Series A | — | Oct 2022 |
| MMorgen | Pre-Seed | $1M | Jul 2022 |
 Morgen | Pre-Seed | $1M | Jul 2022 |
 Ninox | Growth | — | Jan 2022 |
 JenaValve Technology | Series C | $100M | Jan 2022 |
| Sibylla Biotech | Series A | — | Jan 2022 |
| Morgen | Pre-Seed | $1M | Jan 2022 |
 Araris Biotech | Unknown | $24M | Jan 2022 |
 Skribble | Series A | — | Jan 2022 |
 Ledgy | Series A | $10M | Sep 2021 |
 Nexthink | Series D | $180M | Feb 2021 |
| Araris Biotech | Seed | — | Oct 2020 |
 Araris | Seed | — | Oct 2020 |
| iOnctura | Series A | — | Jan 2020 |
| JenaValve Technology | Series A | $50M | Jan 2020 |
| Nexthink | Growth | $85M | Dec 2018 |
 Amal Therapeutics | Series B | — | Nov 2018 |
Page 1 of 3
Top Co-Investors
Schroders Capital8 shared
b2venture6 shared
High-Tech Gründerfonds6 shared
Andera Partners5 shared
Gimv5 shared
Legend Capital5 shared
3B Future Health Fund4 shared
M Ventures4 shared
Cormorant Asset Management4 shared
Hi Inov4 shared
4BIO Capital4 shared
Redalpine4 shared
Pureos Bioventures4 shared
INKEF Capital3 shared
Atlas Venture3 shared
Omega Funds3 shared
IBB Ventures3 shared
Vertis SGR3 shared
Last updated: 20 October 2026